PACB Pacific Biosciences of California, Inc.

2.620USD-2.96%Mkt Cap: 839.24M $P/E: —

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single mol…

Key Statistics

Company
Market Cap839.24M USD
Enterprise Value1.31B USD
Revenue (TTM)159.27M USD
Gross Profit45.78M USD
Net Income (TTM)-546.38M USD
Revenue/Share0.52 USD
Last Price2.620 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees485
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.41
PEG—
EV/EBITDA6.58
EV/Revenue8.23
P/S5.27
P/B-25.23
EPS (TTM)-0.40
EPS (Forward)-0.42
52W Range
1.07066% of range3.435
52W High3.435 USD
52W Low1.070 USD
Profitability
Gross Margin28.61%
Oper. Margin-114.36%
EBITDA Margin125.06%
Profit Margin-341.47%
ROE-10214.54%
ROA-69.68%
Growth
Revenue Growth-1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.21M USD
CapEx (TTM)7.71M USD
FCF Margin183.11%
FCF Yield34.75%
Net Debt472.25M USD
Net Debt/EBITDA2.37
Balance Sheet
Debt/Equity131.32
Current Ratio4.92
Quick Ratio3.90
Book Value/Sh-0.11 USD
Cash/Share0.76 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.157 USD
Upside (mean)-17.7%
Target Range1.250 USD – 3.000 USD
1.250-17.7% to mean3.000
# Analysts7
Ownership
Shares Out.310.83M
Float304.01M
Insiders8.91%
Institutions55.48%
Short Interest
Short Ratio8.0d
Short % Float18.08%
Short % Out.15.73%
Shares Short48.89M
Short (prev mo.)53.41M
Technical
SMA 501.479 (+77.2%)
SMA 2001.583 (+65.5%)
Beta2.19
S&P 52W Chg16.45%
Avg Vol (30d)13.07M
Avg Vol (10d)28.20M
Technical Indicators
RSI (14)79.0
MACD0.3400
MACD Signal0.1961
MACD Hist.+0.1439
BB Upper2.815 USD
BB Middle1.725 USD
BB Lower0.6351 USD
BB Width126.37%
ATR (14)0.2387 USD
Vol Ratio (20d)3.28x